Insider filing · VRDN
Viridian Therapeutics, Inc.
VRDN · Healthcare · 5 filings in 24 months
ticker →
Fairmount Healthcare Fund II L.P. bought $30.0M of Viridian Therapeutics (VRDN)
Executed Sep 13 2024, disclosed Sep 17 2024, 4 days later.
Value, as filed
$30.0M
1,600,000 sh × $18.75
Executed
Sep 13 2024
the trade date, as filed
Disclosed
Sep 17 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
+10.7%
+9.3% from execution
Over the 21 trading sessions from the disclosed entry session (Sep 17 2024), the stock returned +10.7% (delay-adjusted); from the execution session (Sep 13 2024), +9.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
FP
Fairmount Healthcare Fund II L.P.
Director
profile →
Paydirt holds 0 Form 4 reports by Fairmount Healthcare Fund II L.P. from the past 24 months (0 purchases, 0 sales); returns are computed at the next nightly build.
The name
VRDNHealthcare · Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→